Ciclesonide tests its "me too" claim vs Advair for asthma - PulmCCM
Feb 162011

Ciclesonide, a new inhaled corticosteroid that seems to cause thrush less often than others, reached for equivalency with salmeterol/fluticasone in mild persistent asthma. Ciclesonide was better than placebo in controlling asthma but Advair users had a longer time to first asthma exacerbation. CHEST 2011;139: online supplement.
A Cochrane review on ciclesonide could not establish its equivalence with other ICS at higher doses with certainty, but suggested it’s roughly equi-efficacious to fluticasone and other ICS.

Liked this post? Get a weekly email update (no spam, ever), and explore our library of pulmonary and critical care guidelines, practice updates and review articles.

PulmCCM is an independent publication, not affiliated with or endorsed by any other organization, society and/or journal referenced on the website.

Leave a Comment